TrialThe Journal of infectious diseases2020

Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum.

Laura M Smeaton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.